Cargando…
Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis
Pancreatic neuroendocrine neoplasms (pNENs) are slow growing cancers of increasing incidence that lack effective treatments once they become metastatic. Unfortunately, nearly half of pNEN patients present with metastatic liver tumors at diagnosis and current therapies fail to improve overall surviva...
Autores principales: | Kaemmer, Courtney A., Umesalma, Shaikamjad, Maharjan, Chandra K., Moose, Devon L., Narla, Goutham, Mott, Sarah L., Zamba, Gideon K. D., Breheny, Patrick, Darbro, Benjamin W., Bellizzi, Andrew M., Henry, Michael D., Quelle, Dawn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119958/ https://www.ncbi.nlm.nih.gov/pubmed/33986468 http://dx.doi.org/10.1038/s41598-021-89866-1 |
Ejemplares similares
-
RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo
por: Maharjan, Chandra K., et al.
Publicado: (2021) -
RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner
por: Kohlmeyer, Jordan L., et al.
Publicado: (2021) -
Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging
por: Yong, Courtney, et al.
Publicado: (2020) -
Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations
por: Meng, Xiangbing, et al.
Publicado: (2018) -
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
por: Maharjan, Chandra K., et al.
Publicado: (2021)